Jul 2, 2026 06:07AM
Jul 1, 2026 10:39AM
Jun 24, 2026 08:15AM
Jun 15, 2026 06:08AM
Jun 12, 2026 05:49AM
Jun 11, 2026 03:18AM
Jun 8, 2026 03:02AM Novartis to present Rhapsido data at allergy congress
Jun 4, 2026 06:16AM
Jun 1, 2026 07:17AM
May 22, 2026 09:54AM
May 22, 2026 09:25AM
May 7, 2026 09:01AM
May 1, 2026 02:02PM
Apr 30, 2026 07:04AM Novartis announces new API manufacturing facility in North Carolina
Apr 30, 2026 07:01AM
Apr 24, 2026 06:31AM
Apr 9, 2026 03:55AM
Mar 30, 2026 04:18AM
Mar 27, 2026 04:03AM
Mar 23, 2026 04:52AM
Mar 20, 2026 08:21AM Novartis to acquire breast cancer drug developer for up to $3 billion
Mar 16, 2026 12:54PM
Mar 13, 2026 01:37PM
Mar 11, 2026 07:34AM
Mar 11, 2026 04:37AM
Mar 6, 2026 08:35AM
Feb 27, 2026 06:44AM
Feb 18, 2026 06:19AM Novartis reports positive results for remibrutinib in chronic urticaria
Feb 17, 2026 09:37AM
Jan 20, 2026 07:34AM
Jan 16, 2026 12:01PM
Jan 13, 2026 03:07PM
Jan 6, 2026 01:37PM
Dec 31, 2025 06:01AM
Dec 19, 2025 02:32PM Novartis reaches agreement with US government on drug pricing measures
Dec 19, 2025 02:24PM
Dec 19, 2025 02:21PM
Dec 19, 2025 08:51AM
Dec 17, 2025 09:00AM
Dec 12, 2025 07:03AM
Dec 9, 2025 07:33AM
Dec 9, 2025 07:16AM Novartis reports long-term breast cancer treatment data at medical meeting
Dec 3, 2025 04:13AM
Dec 1, 2025 06:53AM
Nov 25, 2025 03:37AM
Nov 24, 2025 09:05AM
Nov 19, 2025 12:36PM
Nov 17, 2025 08:30AM
Nov 12, 2025 05:01PM Novartis malaria drug meets primary endpoint in phase III trial
Nov 10, 2025 09:31AM

423,328 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All